Log In

Term Description

This panel contains terms that genotype CYP3A4 and CYP3A5, determine estimated metabolic activity, and provide interpretations.

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
81642-1CYP3A4 and CYP3A5 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method
Indent81139-8CYP3A4 gene allele [Genotype] in Blood or Tissue by Molecular genetics method NominalO
Indent81140-6CYP3A5 gene allele [Genotype] in Blood or Tissue by Molecular genetics method NominalO
Indent79717-5CYP3A5 gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics methodO
Indent51971-0Gene product metabolic activity interpretation in Blood or Tissue Qualitative by Molecular genetics methodO
Indent81146-3CYP3A4 and CYP3A5 gene targeted mutation analysis in Blood or Tissue by Molecular genetics methodO

LOINC Names Get Info

Fully-Specified Name
CYP3A4 & CYP3A5 gene targeted mutation analysis panel:-:Pt:Bld/Tiss:-:Molgen
Long Common Name
CYP3A4 and CYP3A5 gene targeted mutation analysis panel - Blood or Tissue by Molecular genetics method
Short Name
CYP3A4 + CYP3A5 Pnl Bld/T
Display Name
CYP3A4 and CYP3A5 gene targeted mutation analysis panel Molgen (Bld/Tiss)
Consumer Name Alpha Get Info
CYP3A4 and CYP3A5 gene Targeted Mutation Analysis Panel, Blood or tissue specimen

Part Model Get Info

  • Component
    CYP3A4 & CYP3A5 gene targeted mutation analysis panel
    LP208635-5
    • Analyte
      CYP3A4 & CYP3A5 gene targeted mutation analysis panel
      LP208635-5
      • Component Numerator
        CYP3A4 & CYP3A5 gene targeted mutation analysis panel
        LP208635-5
        • Component Numerator Core
          CYP3A4 & CYP3A5 gene targeted mutation analysis panel
          LP208635-5
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    Bld/Tiss
    LP7061-7
    • System Core
      Bld/Tiss
      LP7061-7
    • Super System
      NULL
       
  • Scale
    -
    LP7747-1
  • Method
    Molgen
    LP6404-0

Basic Attributes

Class
PANEL.MOLPATH.PHARMG
Type
Laboratory
First Released
Version 2.56
Last Updated
Version 2.67 (MIN)
Change Reason
Release 2.67: CLASS: Updated to PANEL.MOLPATH.PHARMG, the more representative LOINC Class for this concept.
Order vs. Observation
Order
Panel Type
Panel

Language Variants Get Info

TagLanguageTranslation
cs-CZCzech (Czechia)Gen CYP3A4 a CYP3A5 cílená mutační analýza panel:-:Časový bod:Krev/tkáň:-:Molekulární genetika
el-GRGreek (Greece)Πίνακας ανάλυσης στοχευμένων μεταλλάξεων των γονιδίων CYP3A4 και CYP3A5:-:Pt:Αίμα/Ιστός:-:Μοριακή γενετική
Synonyms: - MOLPATH MOLPATH.PHARMG PANEL.MOLPATH PANEL.MOLPATH.PHARMG Pt Αίμα Αίμα/Ιστός Γονίδιο Γονίδιο CYP3A4 & CYP3A5 Ιστός Μοριακή γενετική Πίνακας ανάλυσης στοχευμένων μεταλλάξεων των γονιδίων CYP3A4 και CYP3A5
es-ESSpanish (Spain)Panel de análisis de mutaciones dirigidas alos genes CYP3A4 y CYP3A5:Propiedades mixtas (sólo paneles):Punto temporal:Sangre o tejido:-:Genética molecular
es-MXSpanish (Mexico)Panel de análisis de mutaciones dirigidas a los genes CYP3A4 y CYP3A5:-:Punto temporal:Sangre o tejido:-:Genética molecular
fr-FRFrench (France)CYP3A4 et CYP3A5 gène mutation cible trouvée panel:-:Ponctuel:Sang/Tissu:-:Biologie moléculaire
it-ITItalian (Italy)Analisi della mutazione del gene CYP3A4 & CYP3A,panel:-:Pt:Sangue/Tess:-:Molgen
Synonyms: Farmacogenomica Gene CYP3A4 e CYP3A5 Gene CYP3A5 Genetica molecolare Panel Analisi della mutazione del gene CYP3A4 e CY Panel farmacogenomica Patologia molecolare Punto nel tempo (episodio) Sangue Sangue o Tessuto Set di prescrizione patologia molecolare Tessuto & Strisci
nl-NLDutch (Netherlands)CYP3A4 & CYP3A5-gen doelgerichte mutatie analyse panel:-:moment:bloed of weefsel:-:moleculair genetisch onderzoek
Synonyms: CYP3A4 & CYP3A5 gen CYP3A4 & CYP3A5 gen gerichte mutatie analyse panel molgen
pl-PLPolish (Poland)Analiza panelu mutacji ukierunkowanych na geny CYP3A4 & CYP3A5:-:punkt w czasie:krew lub tkanka:-:genetyka molekularna
Synonyms: Analiza mutacji genów CYP3A4 i CYP3A5 Analiza panelu mutacji ukierunkowanych na geny CYP3A4 i CYP3A5 diagnostyka molekularna Geny CYP3A4 i CYP3A5
zh-CNChinese (China)CYP3A4 与 CYP3A5 基因靶向突变分析组套:-:时间点:全血/组织:-:分子遗传学类实验室方法
Synonyms: CYP3A4 与 CYP3A5 基因靶向突变分析（目标突变分析、定向突变分析）组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;细胞色素 P450, 家族 3, 亚家族 A, 多肽 4;cytochrome P450, family 3, subfamily A, polypeptide 4;细胞色素 P450, 家族 3, 亚家族 A, 多肽 5;cytochrome P450, family 3, subfamily A, polypeptide 5 EC 1.14.14.1;细胞色素 P450 家族 3 亚家族 A 成员 5;细胞色素 P450, 亚家族 IIIA (硝苯吡啶氧化酶), 多肽 5;细胞色素 P450, 家族 3, 亚家族 A, 多肽 5;细胞色素 P450 HLp2;细胞色素 P450-PCN3;Cytochrome P450 Family 3 Subfamily A Member 5;Cytochrome P450, Subfamily IIIA (Niphedipine Oxidase), Polypeptide 5 全血或组织;血液/组织;血液或组织 分子病理学;分子病理学试验 分子遗传学;分子遗传学方法;分子遗传学类方法;分子遗传学类检验方法;包括 RFL、PCR 及其他方法在内，用于在分子基础上检测遗传属性的方法的大类;聚合酶链反应;聚合酶链式反应 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.分子病理学;分子病理学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）.药物基因组学（药物基因体学、药物基因学、药物基因组）;分子病理学医嘱组类;医嘱组类.分子病理学;实验室医嘱组类.分子病理学 医嘱组.分子病理学;分子病理学组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）;分子病理学医嘱组类;医嘱组类.分子病理学;实验室医嘱组类.分子病理学 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 未作说明的组织;组织;组织 & 涂片 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 组 组合 组合医嘱 组合类 组套 细胞色素 P450, 家族 3, 亚家族 A, 多肽 4;cytochrome P450, family 3, subfamily A, polypeptide 4;细胞色素 P450, 家族 3, 亚家族 A, 多肽 5;cytochrome P450, family 3, subfamily A, polypeptide 5 血;血液 遗传基因;遗传因子;吉恩;生物基因

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=81642-1
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/81642-1